Brief: Medivir Says Positive Results From Investigator-Initiated Phase II Clinical Study Of Remetinostat In Patients With Squamous Cell Carcinoma Published
20/05/2021 17:15
May 20 (Reuters) - Medivir AB MVIRb.ST :
* MEDIVIR - POSITIVE RESULTS FROM INVESTIGATOR-INITIATED
PHASE II
CLINICAL STUDY OF REMETINOSTAT IN PATIENTS WITH SQUAMOUS CELL
CARCINOMA PUBLISHED
* MEDIVIR AB MVIRb.ST - NO SYSTEMIC ADVERSE EVENTS WERE
REPORTED
* MEDIVIR - ALL PATIENTS EXPERIENCED A LOCALIZED CUTANEOUS
REACTION IN RESPONSE TO TREATMENT, WHICH REQUIRED ONE PATIENT TO
DISCONTINUE THERAPY
Source text for Eikon: ID:nWkr73HJqZ
Further company coverage: MVIRb.ST
((Reuters.Briefs@thomsonreuters.com;))